In this episode, Steve Gardner sits down with Paul Jones, CEO of Biopharma Solutions at M42, to explore the transformative potential of genomic science across the biopharma value chain and more. From large-scale DNA sequencing to the real-world applications of genomics in personalising medicine, Paul shares how this powerful technology is reshaping drug development, disease prediction, and clinical trials.

Discover what a genome is, how it’s sequenced, and why it matters. Learn how pharma and biotech industries are leveraging genomic data to develop precision medicines tailored to people like you. The conversation also delves into the role of genomics in preventative healthcare and its emerging impact in pharmacogenetics, where treatments are tailored based on individual genetic profiles.